Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d'Oncologie Pédiatrique.

[1]  J. Delattre,et al.  Brain stem gliomas , 2001, Current opinion in neurology.

[2]  R. Oberbauer,et al.  Outcome and Long-Term Side Effects after Synchronous Radiochemotherapy for Childhood Brain Stem Gliomas , 2001, Pediatric Neurosurgery.

[3]  H. Friedman,et al.  Paclitaxel for the Treatment of Progressive or Recurrent Childhood Brain Tumors: A Pediatric Oncology Phase II Study , 2001, Journal of pediatric hematology/oncology.

[4]  R. Kortmann,et al.  Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme , 2000, Cancer.

[5]  H. Friedman,et al.  A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? , 2000, International journal of radiation oncology, biology, physics.

[6]  V. Lanchote,et al.  Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Ferrari,et al.  Concomitant chemoradiotherapy for childhood poor-prognosis gliomas. , 2000, Medical and pediatric oncology.

[8]  E. Bouffet,et al.  Radiotherapy followed by high dose busulfan and thiotepa , 2000, Cancer.

[9]  I. Pollack,et al.  Chemotherapy for high-grade gliomas of childhood , 1999, Child's Nervous System.

[10]  A. Nirenberg,et al.  A Phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas , 1999, Cancer.

[11]  M. Sokal,et al.  Clinical management of brain stem glioma , 1999, Archives of disease in childhood.

[12]  P. Burger,et al.  There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[13]  B. Donahue,et al.  Patterns of recurrence in brain stem gliomas: evidence for craniospinal dissemination. , 1998, International journal of radiation oncology, biology, physics.

[14]  A. Brandes,et al.  Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme , 1998, Cancer.

[15]  J. Farmer,et al.  Pediatric brain stem gliomas: a review. , 1998, International journal of radiation oncology, biology, physics.

[16]  A. Gholkar,et al.  UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group. , 1997, International journal of radiation oncology, biology, physics.

[17]  R. Zimmerman,et al.  Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant β‐interferon and hyperfractionated radiation therapy: A Childrens Cancer Group phase I/II study , 1996, Cancer.

[18]  B. Jeremic,et al.  Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  R. Zimmerman,et al.  Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A childrens cancer group phase 1/11 trial , 1994, Cancer.

[20]  J. Krischer,et al.  Pre‐irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the pediatric oncology group, protocol 8833 , 1993, Cancer.

[21]  M. Mokry,et al.  Hyperfractionated radiotherapy and polychemotherapy in brain stem tumors in children , 1992, Child's Nervous System.

[22]  W. J. Oakes,et al.  Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Crooijmans,et al.  Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. , 1991, International journal of radiation oncology, biology, physics.

[24]  P. Gaynon,et al.  Carboplatin in childhood brain tumors: A children's cancer study group phase II trial , 1990, Cancer.

[25]  J Benichou,et al.  Application of the triangular test to phase II cancer clinical trials. , 1990, Statistics in medicine.

[26]  R. R. Smith,et al.  Pediatric brainstem glioma , 1990, Neuroradiology.

[27]  M. Schell,et al.  Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  W. Wara,et al.  Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group. , 1987, Journal of neurosurgery.

[29]  E. Douple,et al.  Carboplatin as a potentiator of radiation therapy. , 1985, Cancer treatment reviews.

[30]  R. Zimmerman,et al.  Pediatric brain stem gliomas , 1980, Cancer.

[31]  M. Ohkawa,et al.  Intra-arterial chemotherapy for brain stem glioma: report of four cases , 2004, Neuroradiology.

[32]  J. Langston,et al.  Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study. , 1998, Medical and pediatric oncology.

[33]  R. Kane,et al.  The results of a five‐year early prostate cancer detection intervention , 1996, Cancer.

[34]  R. Zimmerman,et al.  Brainstem Gliomas in Children , 1996 .

[35]  F. Doz,et al.  What is the place of carboplatin in paediatric oncology? , 1994, European journal of cancer.